Greg Arms has been appointed to the Board of Directors of IS Benefits!

Hooksett, New Hampshire – Integrated Solutions for Benefits and Insurance Services (IS Benefits), a company providing stop-loss insurance, specialty drug management, and claims auditing for self-funded employers, announced today that Greg Arms has been appointed to the Company's Board of Directors as a member.

Greg has over 40 years of global experience in the insurance and employee benefits industry. Throughout his career, he has held senior positions at leading insurance firms, including Chubb Group of Insurance Companies (Global Accident and Health Manager), Marsh & McLennan (Global Co-Leader, Mercer Marsh Benefits), Willis Group (President and CEO, Global Employee Benefits Practice), UnitedHealth Group (International Marketing Manager) and AIG (President / Director of Global Management Division).

Nancy Young, Founder of IS Benefits, said, “At IS Benefits, we are ready to grow in terms of scale and capability. Greg's industry knowledge, sales and marketing experience, and leadership in employee benefits will greatly accelerate our ability to deliver innovative stop-loss and specialty drug solutions to self-funded employers. We are thrilled to have him on our Board of Directors.”

Greg Arms stated, “I am very excited to join IS Benefits. The company has built a strong foundation of experience and customer trust on this dynamic journey. I look forward to expanding our impact to provide meaningful value for self-funded employers and their employees by leveraging innovation, analytics, and strategic partnerships.”

Integrated Solutions was founded in 2006 and is headquartered in Hooksett, New Hampshire. IS Benefits partners with health organizations, employers, and brokers to simplify the complexities of high-risk and stop-loss coverage. The company combines deep expertise in stop-loss insurance, specialty drug management, and claims auditing with a highly consultative approach.

Argosy Healthcare Partners is a mid-sized private equity firm focused specifically on healthcare. AHP conducts control transactions by partnering with founder-owned healthcare businesses with EBITDA of $1.0 – $3.0 million across the United States. AHP is a platform designed to support the cultures of founder-owned companies, reinvest in their businesses, and accelerate growth.